FILGOTINIB, A SELECTIVE JANUS KINASE 1 (JAK1) INHIBITOR, MODULATES DISEASE-ASSOCIATED CYTOKINES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

被引：0
|
作者：
Taylor, Peter C. [1 ]
Elboudwarej, Emon [2 ]
LI Wanying [2 ]
Hawtin, Rachael E. [2 ]
Liu, Jinfeng [2 ]
Mirza, Amer M. [2 ]
机构：
[1] Univ Oxford, Botnar Res Ctr, Oxford, England
[2] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2510
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0133
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [21] THE JAK1 SELECTIVE INHIBITOR FILGOTINIB REGULATES BOTH ENTHESIS AND COLON INFLAMMATION IN A MOUSE MODEL OF PSORIATIC ARTHRITIS
    Robin-Jagerschmidt, C.
    Lavazais, S.
    Marsais, F.
    Ongenaert, M.
    Monjardet, A.
    Cauvin, A.
    Saccomani, C.
    Parent, I
    Merciris, D.
    Chanudet, E.
    Blanque, R.
    Borgonovi, M.
    Lepescheux, L.
    Auberval, M.
    Dupont, S.
    Clement-Lacroix, P.
    Galien, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 733 - 733
  • [22] Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials
    Jacqueline M. Tarrant
    René Galien
    Wanying Li
    Lovely Goyal
    Yang Pan
    Rachael Hawtin
    Wangshu Zhang
    Annegret Van der Aa
    Peter C. Taylor
    Rheumatology and Therapy, 2020, 7 : 173 - 190
  • [23] THE JAK1 SELECTIVE INHIBITOR FILGOTINIB REGULATES BOTH ENTHESIS AND COLON INFLAMMATION IN A MOUSE MODEL OF PSORIATIC ARTHRITIS
    Robin-Jagerschmidt, C.
    Lavazais, S.
    Marsais, F.
    Monjardet, A.
    Cauvin, A.
    Saccomani, C.
    Parent, I.
    Merciris, D.
    Chanudet, E.
    Borgonovi, M.
    Lepescheux, L.
    Auberval, M.
    Dupont, S.
    Clement-Lacroix, P.
    Galien, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 118 - 119
  • [24] The JAK1-Selective Inhibitor Filgotinib Displays an Anti-Inflammatory Biomarker Signature in Rheumatoid Arthritis Patients
    Taylor, Peter C.
    Westhovens, R.
    Meuleners, Luc
    Meuleman, Birgen
    Pan, Yang
    Vyncke, Veerle
    Van der Aa, Annegret
    Harrison, Pille
    Tasset, Chantal
    Galien, Rene
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [25] Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
    Mark Genovese
    Rene Westhovens
    Luc Meuleners
    Annegret Van der Aa
    Pille Harrison
    Chantal Tasset
    Arthur Kavanaugh
    Arthritis Research & Therapy, 20
  • [26] Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
    Genovese, Mark
    Westhovens, Rene
    Meuleners, Luc
    Van der Aa, Annegret
    Harrison, Pille
    Tasset, Chantal
    Kavanaugh, Arthur
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [27] Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials
    Tarrant, Jacqueline M.
    Galien, Rene
    Li, Wanying
    Goyal, Lovely
    Pan, Yang
    Hawtin, Rachael
    Zhang, Wangshu
    Van der Aa, Annegret
    Taylor, Peter C.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (01) : 173 - 190
  • [28] Response of rheumatoid arthritis-associated pyoderma gangrenous to the JAK1 inhibitor upadacitinib
    Kooybaran, Neda Rahbar
    Korsten, Peter
    Schoen, Michael P.
    Moessner, Rotraut
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (04): : 522 - 524
  • [29] BARICITINIB Tyrosine-Protein Kinase JAK1/JAK2 Inhibitor Treatment of Rheumatoid Arthritis
    Gras, Jordi
    DRUGS OF THE FUTURE, 2013, 38 (09) : 611 - 617
  • [30] Selective JAK1 Inhibition with Filgotinib (GLPG0634) Decreases Plasma Markers of Inflammation and Joint Damage in Patients with Rheumatoid Arthritis
    Galien, Rene
    Van der Aa, Annegret
    Blanque, Roland
    Darquenne, Sophie
    Harrison, Pille
    Tasset, Chantal
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345